177 related articles for article (PubMed ID: 22743590)
21. Design and synthesis of aminocoumarin derivatives as DPP-IV inhibitors and anticancer agents.
Soni R; Soman SS
Bioorg Chem; 2018 Sep; 79():277-284. PubMed ID: 29783098
[TBL] [Abstract][Full Text] [Related]
22. Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights.
Sabt A; Eldehna WM; Al-Warhi T; Alotaibi OJ; Elaasser MM; Suliman H; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1616-1630. PubMed ID: 32781872
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
[TBL] [Abstract][Full Text] [Related]
24. Diarylurea derivatives comprising 2,4-diarylpyrimidines: Discovery of novel potential anticancer agents via combined failed-ligands repurposing and molecular hybridization approaches.
Farag AK; Hassan AHE; Chung KS; Lee JH; Gil HS; Lee KT; Roh EJ
Bioorg Chem; 2020 Oct; 103():104121. PubMed ID: 32745753
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and cytotoxic evaluation of some new phthalazinylpiperazine derivatives.
Liu Y; Zhang S; Li Y; Wang J; Song Y; Gong P
Arch Pharm (Weinheim); 2012 Apr; 345(4):287-93. PubMed ID: 22006840
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, cytotoxicity, apoptosis and molecular docking studies of novel phenylbutyrate derivatives as potential anticancer agents.
Mostoufi A; Baghgoli R; Fereidoonnezhad M
Comput Biol Chem; 2019 Jun; 80():128-137. PubMed ID: 30952039
[TBL] [Abstract][Full Text] [Related]
27. A QSAR study on a series of pyrrole derivatives acting as lymphocyte-specific kinase (Lck) inhibitors.
Anwer Z; Gupta SP
Med Chem; 2012 Jul; 8(4):649-55. PubMed ID: 22548340
[TBL] [Abstract][Full Text] [Related]
28. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
30. In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α.
Singh K; Munuganti RS; Leblanc E; Lin YL; Leung E; Lallous N; Butler M; Cherkasov A; Rennie PS
Breast Cancer Res; 2015 Feb; 17(1):27. PubMed ID: 25848700
[TBL] [Abstract][Full Text] [Related]
31. Plant polyphenol induced cell death in human cancer cells involves mobilization of intracellular copper ions and reactive oxygen species generation: a mechanism for cancer chemopreventive action.
Khan HY; Zubair H; Faisal M; Ullah MF; Farhan M; Sarkar FH; Ahmad A; Hadi SM
Mol Nutr Food Res; 2014 Mar; 58(3):437-46. PubMed ID: 24123728
[TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
33. 5-Substituted [1]pyrindine derivatives with antiproliferative activity.
Kolb S; Goddard ML; Loukaci A; Mondésert O; Ducommun B; Braud E; Garbay C
Eur J Med Chem; 2010 Mar; 45(3):896-901. PubMed ID: 19969400
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS
Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421
[TBL] [Abstract][Full Text] [Related]
35. Novel selenadiazole derivatives as selective antitumor and radical scavenging agents.
Ruberte AC; Plano D; Encío I; Aydillo C; Sharma AK; Sanmartín C
Eur J Med Chem; 2018 Sep; 157():14-27. PubMed ID: 30071406
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of functionalized amino acid derivatives as new pharmacophores for designing anticancer agents.
Kumar V; Mudgal MM; Rani N; Jha A; Jaggi M; Singh AT; Sanna VK; Singh P; Sharma PK; Irchhaiya R; Burman AC
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):763-70. PubMed ID: 18720190
[TBL] [Abstract][Full Text] [Related]
37. Tyrosine 319 in the interdomain B of ZAP-70 is a binding site for the Src homology 2 domain of Lck.
Pelosi M; Di Bartolo V; Mounier V; Mège D; Pascussi JM; Dufour E; Blondel A; Acuto O
J Biol Chem; 1999 May; 274(20):14229-37. PubMed ID: 10318843
[TBL] [Abstract][Full Text] [Related]
38. Development of tetrahydroisoquinoline-based hydroxamic acid derivatives: potent histone deacetylase inhibitors with marked in vitro and in vivo antitumor activities.
Zhang Y; Feng J; Jia Y; Wang X; Zhang L; Liu C; Fang H; Xu W
J Med Chem; 2011 Apr; 54(8):2823-38. PubMed ID: 21476600
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and cytotoxic evaluation of novel symmetrical taspine derivatives as anticancer agents.
Zhang J; Zhang Y; Pan X; Wang S; He L
Med Chem; 2011 Jul; 7(4):286-94. PubMed ID: 21568882
[TBL] [Abstract][Full Text] [Related]
40. Novel Nicotinonitrile Derivatives Bearing Imino Moieties Enhance Apoptosis and Inhibit Tyrosine Kinase.
El-Hashash MA; El-Bordany EA; Marzouk MI; El-Naggar AM; Nawar TMS; El-Sayed WM
Anticancer Agents Med Chem; 2018; 18(11):1589-1598. PubMed ID: 29745342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
